Across sub-Saharan Africa, approximately 42% of patients do not take their medication as prescribed. The consequences — avoidable complications, hospitalisations, and deaths — represent one of the most costly and underaddressed challenges in African healthcare.
The Scale of the Problem
Non-adherence is not a uniquely African phenomenon. But in Africa, the consequences are amplified by fragmented healthcare systems, out-of-pocket cost sensitivity, and low health literacy in many populations. A patient who cannot afford the transport cost to collect a refill, or who does not understand the long-term consequences of stopping a medication, makes a rational short-term decision with catastrophic long-term effects.
For pharma companies, non-adherence translates directly into lost revenue — a patient who stops a chronic disease medication at month two is not generating the projected lifetime value the brand model assumed. For HMOs and insurers, non-adherent patients present with more severe conditions later, at dramatically higher claims cost. For hospital systems, the revolving door of readmissions driven by poor post-discharge adherence is one of the most significant operational drains on bed capacity.
The Behavioural Science Case for Rewards
Decades of behavioural economics research — from Kahneman and Thaler to more recent applied health studies — consistently demonstrates that small, immediate rewards are dramatically more effective at changing behaviour than distant, abstract consequences. The human brain discounts future outcomes steeply. A patient who knows abstractly that taking their blood pressure medication will reduce their stroke risk in ten years responds very differently to a patient who earns 200 Reward Units — redeemable for airtime today — upon confirming a refill.
This is not a novel insight. Conditional cash transfer programs in public health have demonstrated measurable adherence improvements across multiple African contexts. The problem has never been whether rewards work. The problem has been infrastructure.
Why the Infrastructure Gap Matters
Until recently, any organisation that wanted to run a structured patient reward program in an African market faced a daunting set of operational challenges: How do you deliver a reward to a patient who may not have a bank account? How do you verify that a patient actually took a medication rather than simply claiming to? How do you run the same program simultaneously across Nigeria, Kenya, and Ghana without building a separate operational stack in each market? How do you measure the campaign ROI in a way that satisfies a finance director or a board?
These questions have historically been answered with expensive custom builds, agency workarounds, or simply — not at all. The investment required to answer them properly has meant that reward-based adherence programs have been limited to well-capitalised multinational pharma companies with the budget and patience for multi-year infrastructure projects.
The Infrastructure Now Exists
The convergence of several factors — mobile money penetration, WhatsApp adoption, digital gift card infrastructure, and API-first product design — has made it possible to build the reward delivery layer that African healthcare was missing.
A patient in Lagos can be issued Reward Units via WhatsApp within seconds of a pharmacist scanning a QR code at the point of dispensing. The same system can simultaneously run a USSD-based program for rural patients in northern Nigeria who have no smartphone access. The same dashboard tracks redemption rates, cost per action, and geographic breakdown in real time.
What This Means for Healthcare Organisations
For pharma, the implication is straightforward: adherence programs that were previously only viable at large scale, with large budgets, are now accessible to mid-market brands. The barrier to entry has dropped from a multi-million naira infrastructure build to a platform subscription and a campaign brief.
For hospitals and HMOs, the same infrastructure applies to a broader set of behaviour-change objectives — appointment attendance, post-discharge check-ins, in-network utilisation, plan renewal. Any behaviour that can be verified can be rewarded. Any reward that can be issued digitally can be tracked and attributed.
The reward is not the strategy. The reward is the delivery mechanism for a behaviour-change strategy that the healthcare sector has understood for years but lacked the tools to execute at scale. That gap has closed.